A panel of genes methylated with high frequency in colorectal cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Mitchell, Susan M ^a   Ross, Jason P ^a   Drew, Horace R ^a   Ho, Thu ^a   Brown, Glenn S ^a   Saunders, Neil F W ^a   Duesing, Konsta R ^a   Buckley, Michael J ^a   Dunne, Rob ^a   Beetson, Iain ^b   Rand, Keith N ^a   McEvoy, Aidan ^b   Thomas, Melissa L ^b   Baker, Rohan T ^b   Wattchow, David A ^c   Young, Graeme P ^c   Lockett, Trevor J ^a   Pedersen, Susanne K ^b   LaPointe, Lawrence C ^b   Molloy, Peter L ^a  

^a CSIRO   (Australia)

^b Clinical Genomics Pty Ltd   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Biomarker; Colorectal cancer; DNA methylation

Indexed keywords

COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HCT116 CELLS; HT29 CELLS; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893197219     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-54     Document Type: Article

References (44)

1. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011, 11:726-734. 10.1038/nrc3130, 3307543, 21941284.
2. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 2013, 13:497-510. 10.1038/nrc3486, 23760024.
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007, 128:683-692. 10.1016/j.cell.2007.01.029, 3894624, 17320506.
4. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011, 8:686-700. 10.1038/nrgastro.2011.173, 3391545, 22009203.
5. Ross JP, Rand KN, Molloy PL. Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2010, 2:245-269. 10.2217/epi.10.2, 22121873.
6. Hinoue T, Weisenberger DJ, Lange CPE, Shen H, Byun H-M, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012, 22:271-282. 10.1101/gr.117523.110, 3266034, 21659424.
7. Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, et al. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics 2012, 7:1355-1367. 10.4161/epi.22562, 3528691, 23079744.
8. Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 2012, 13:84.
9. Kondo Y, Issa JPJ. Epigenetic changes in colorectal cancer. Canc Metastasis Rev 2004, 23:29-39.
10. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Weisenberger DJ, Laird PW, Loda M, Fuchs CS. Quantitative DNA methylation analysis determines CpG island methylation phenotype (CIMP) as a distinct subtype of colorectal cancer. Mod Pathol 2006, 19:116A-116A.
11. Li X, Yao X, Wang Y, Hu F, Wang F, Jiang L, Liu Y, Wang D, Sun G, Zhao Y. MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS One 2013, 8:e59064. 10.1371/journal.pone.0059064, 3612054, 23555617.
12. de Vos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Gruetzmann R, Pilarsky C, Habermann JK, Fleshner P, et al. Circulating Methylated Septin 9 DNA in Plasma Is a Biomarker for Colorectal Cancer. Gastroenterology 2009, 136:A623-A623.
13. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu SL, Dawson D, Willis J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005, 97:1124-1132. 10.1093/jnci/dji204, 16077070.
14. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011, 6:692-702. 10.4161/epi.6.6.16196, 21593595.
15. Drew HR, Molloy PL, Brown GS. Identifying methylated cytosine bases in nucleotide sequence involves generating fragments containing base having unmethylated cytosine/methylcytosine of DNA molecule with nucleotide sequence, followed by incubating and detecting. 2011, WO2011017760-A1-AU2010282225-A1. : , Patent application.
16. Ross JP, Shaw JM, Molloy PL. Identification of differentially methylated regions using streptavidin bisulfite ligand methylation enrichment (SuBLiME), a new method to enrich for methylated DNA prior to deep bisulfite genomic sequencing. Epigenetics 2013, 8:113-127. 10.4161/epi.23330, 3549874, 23257838.
17. Ang PW, Loh M, Liem N, Lim PL, Grieu F, Vaithilingam A, Platell C, Yong WP, Iacopetta B, Soong R. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 2010, 10:227. 10.1186/1471-2407-10-227, 2880997, 20492682.
18. Kim Y-H, Lee HC, Kim S-Y, Il Yeom Y, Ryu KJ, Min B-H, Kim D-H, Son HJ, Rhee P-L, Kim JJ, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 2011, 18:2338-2347. 10.1245/s10434-011-1573-y, 3393129, 21298349.
19. Lange CPE, Campan M, Hinoue T, Schmitz RF, van der Meulen-de Jong AE, Slingerland H, Kok PJMJ, van Dijk CM, Weisenberger DJ, Shen H, et al. Genome-scale discovery of DNA-Methylation biomarkers for blood-based detection of colorectal cancer. Plos One 2012, 7:e50266. 10.1371/journal.pone.0050266, 3508917, 23209692.
20. Oster B, Thorsen K, Lamy P, Wojdacz TK, Hansen LL, Birkenkamp-Demtroder K, Sorensen KD, Laurberg S, Omtoft TF, Andersen CL. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer 2011, 129:2855-2866. 10.1002/ijc.25951, 21400501.
21. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, Isagawa T, Midorikawa Y, Nishimura Y, Sakamoto H, Seto Y, et al. Three DNA Methylation Epigenotypes in human colorectal cancer. Clin Cancer Res 2010, 16:21-33. 10.1158/1078-0432.CCR-09-2006, 20028768.
22. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008, 7:94. 10.1186/1476-4598-7-94, 2639620, 19117505.
23. Irizarry RA, Ladd-Acosta C, Wen B, Wu ZJ, Montano C, Onyango P, Cui HM, Gabo K, Rongione M, Webster M, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009, 41:178-186. 10.1038/ng.298, 2729128, 19151715.
24. Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, Rahaman R, Dodsworth C, Rakibuz-Zaman M, Kamal M, Ahsan H. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med Genom 2011, 4:50.
25. Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, Kim TS, Kim NK, Chung HC, An S. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn 2012, 15:498-507.
26. Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, et al. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer 2011, 10:85. 10.1186/1476-4598-10-85, 3166273, 21777459.
27. Bibikova M, Lin ZW, Zhou LX, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang YH, Vollmer E, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006, 16:383-393. 10.1101/gr.4410706, 1415217, 16449502.
28. Wilson CL, Miller CJ. Simpleaffy: a BioConductor package for Affymetrix quality control and data analysis. Bioinformatics 2005, 21:3683-3685. 10.1093/bioinformatics/bti605, 16076888.
29. Smyth GK, et al. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman R.
30. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140. 10.1093/bioinformatics/btp616, 2796818, 19910308.
31. David M, Dzamba M, Lister D, Ilie L, Brudno M. SHRiMP2: sensitive yet practical short read mapping. Bioinformatics 2011, 27:1011-1012. 10.1093/bioinformatics/btr046, 21278192.
32. LaPointe LC, Pedersen SK, Dunne R, Brown GS, Pimlott L, Gaur S, McEvoy A, Thomas M, Wattchow D, Molloy PL, Young GP. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS One 2012, 7:e29059. 10.1371/journal.pone.0029059, 3261845, 22276102.
33. Javierre BM, Rodriguez-Ubreva J, Al-Shahrour F, Corominas M, Grana O, Ciudad L, Agirre X, Pisano DG, Valencia A, Roman-Gomez J, et al. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells. Mol Cancer Res 2011, 9:1139-1151. 10.1158/1541-7786.MCR-10-0515, 21737484.
34. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337. 10.1038/nature11252, 3401966, 22810696.
35. Gu H, Bock C, Mikkelsen TS, Jager N, Smith ZD, Tomazou E, Gnirke A, Lander ES, Meissner A. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 2010, 7:133-U169. 10.1038/nmeth.1414, 2860480, 20062050.
36. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548. 10.1093/bioinformatics/btn224, 18467348.
37. de Vos T, Lofton-Day C, Model F, Sledziewski A, Liebenberg V, Day R. Methylated Septin 9 DNA: a biomarker found in blood plasma, for the detection of colorectal cancer. Clin Chem 2007, 53:A109-A109.
38. Liang GN, Robertson KD, Talmadge C, Sumegi J, Jones PA. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res 2000, 60:4907-4912.
39. Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol 2008, 294:1-9. 10.1016/j.mce.2008.07.006, 18687378.
40. Mwangi SM, Usta Y, Shahnavaz N, Joseph I, Avila J, Cano J, Chetty VK, Larsen CP, Sitaraman SV, Srinivasan S. Glial cell line-derived neurotrophic factor enhances human Islet Posttransplantation survival. Transplantation 2011, 92:745-751. 10.1097/TP.0b013e31822bc95a, 3684966, 21869742.
41. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006, 38:540-549. 10.1038/ng1781, 16642018.
42. Coolen M, Song J, Statham AL, Lacaze P, Moreno CS, Kaplan W, Stirzaker C, Clark SJ. Long range epigenetic silencing (LRES): a common phenomenon in prostate cancer. Cell Oncol 2008, 30:225-225.
43. Dallosso AR, Hancock AL, Szemes M, Moorwood K, Chilukamarri L, Tsai H-H, Sarkar A, Barasch J, Vuononvirta R, Jones C, et al. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor. PLoS genetics 2009, 5:e1000745. 10.1371/journal.pgen.1000745, 2776977, 19956686.
44. Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE. A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol 2013, 3:e27.